The administration of the anti-IL-17 antibody significantly reduced pSTAT3 expression in STAT1-/- animals, suggesting that IL-17 may promote tumor growth in the absence of STAT1 through the activation of the STAT3 signaling pathway. This evidence concerns the gene STAT3 and neoplasm.